Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Tomato juice may help type 2 diabetics

Tomato juice may be the key to decreasing hyperactive platelet aggregation, which can lead to heart disease, according to the latest nutrition and dietetics study by HMRI researchers based at the University of Newcastle.

27 Aug 2004

Study emphasizes the importance of monitoring blood pressure and dyslipidemia in patient's with metabolic syndrome

Having three or more traits of the metabolic syndrome significantly increases the risk of dying from coronary heart disease, cardiovascular disease or any other cause, according to a study in Circulation: Journal of the American Heart Association.

25 Aug 2004

Diabetes worldwide will continue to increase at record levels

The number of people with diabetes worldwide will continue to increase at record levels through 2030, with the greatest relative increase in prevalence expected in the Middle Eastern Crescent, sub-Saharan Africa and India, according to a study published in the May issue of Diabetes Care.

22 Aug 2004

People with type 2 diabetes could benefit from atorvastatin

Results of a randomised trial in this week’s issue of THE LANCET suggest that people with type 2 diabetes could benefit from cholesterol-lowering therapy with statins to reduce the risk of cardiovascular disease, even when they do not have high cholesterol concentrations.

20 Aug 2004

Embryonic stem cell therapy show benefits in rebuilding damaged heart

Despite improvements in earlier diagnosis and treatment, cardiovascular disease is far and away the leading cause of death in the U.S. and the world.

18 Aug 2004

Vitamin E has potential benefit in fighting colds in the elderly

Vitamin E supplementation has potential benefit in fighting upper respiratory tract infections such as colds in the elderly, says a study published in the Aug. 18 issue of JAMA.

18 Aug 2004

Good health goes beyond diet, exercise and stress

While pleasurable experiences may lift your spirits, the ones that leave you with a sense of purpose and meaningful relationships may do even more: protect the body against ill health.

15 Aug 2004

Ways to economically recover recombinant proteins from transgenic tobacco

The economics of producing biopharmaceuticals from transgenic plants such as tobacco is still a roadblock to producing large quantities of urgently needed medicines, especially for people in underdeveloped nations.

12 Aug 2004

Link between short-term hormone therapy (HT) and improvements in life quality for women with menopausal symptoms

An article in the current issue of the Archives of Internal Medicine explains how a computer based simulation model has found a link between short-term hormone therapy (HT) and improvements in life quality for women with menopausal symptoms. The article also points out that short-term hormone therapy may actually shorten life expectancy.

10 Aug 2004

Clinical trial of lipase inhibitor for the treatment of obesity

Peptimmune, Inc. a privately held biotechnology company, announced that physicians have treated the first participant in a clinical trial to evaluate the safety, tolerability and pharmacokinetics of GT389-255, a lipase inhibitor conjugated to a fat binding polymer for the treatment of obesity.

9 Aug 2004

Effects of oxidative stress on atherosclerosis

Heart disease and stroke are the first and third leading causes of death among men and women in the United States and account for 40 percent of all mortalities, according to the Centers for Disease Control and Prevention.

9 Aug 2004

Novel treatment of patients with high cholesterol focus of national meeting

Implications of recent lipid-lowering clinical trials and the specific changes to the NCEP guidelines will be the focus of discussion by Neil J. Stone, M.D., professor of clinical medicine of the Feinberg School of Medicine at Northwestern University.

6 Aug 2004

Current estimates have cardiovascular disease (CVD) accounting for 17 million deaths annually

Renowned public health specialist, Professor Stephen Leeder, will present the central findings of a report highlighting the disturbing trend towards a growth in cardiovascular disease in developing countries, at a special colloquium to be held at The University of Sydney.

5 Aug 2004

Approval of cholesterol-lowering therapy Lipitor for the prevention of cardiovascular disease

Pfizer has announced that the U.S. Food and Drug Administration has approved its cholesterol-lowering therapy Lipitor® (atorvastatin calcium) for the prevention of cardiovascular disease by reducing heart attack risk in people with normal to mildly elevated cholesterol levels who have other cardiovascular risk factors.

5 Aug 2004

Atherosclerosis at menopause slowed by diet and exercise

Thickening of artery walls accelerates as women enter menopause, but these signs of the progression of atherosclerosis can be slowed by a lower-fat diet and increased physical activity, according to a new study in the Aug. 4, 2004, issue of the Journal of the American College of Cardiology.

5 Aug 2004

FDA has granted orphan drug designation to Myogen's ambrisentan, for the treatment of pulmonary arterial hypertension

Myogen has announced that the United States Food and Drug Administration has granted orphan drug designation to ambrisentan for the treatment of pulmonary arterial hypertension (PAH).

3 Aug 2004

Antioxidant pills do nothing to prevent cardiovascular disease

Research published in the current issue of the Journal of the American Heart Association, shows that antioxidant pills have no clear benefit in the prevention of cardiovascular disease.

2 Aug 2004

Connection between air pollution and cardiovascular disease

Researchers at the University of Washington will direct the largest study of its kind to explore the connection between air pollution and the No. 1 cause of death in the United States: cardiovascular disease.

2 Aug 2004

Isolated soy protein shown to benefit type 2 diabetics

Isolated soy protein added to the diets of 14 men, all military veterans under treatment for advanced stages of type 2 diabetes, significantly lowered unwanted proteins in their urine and slightly raised desired HDL cholesterol levels in their blood, researchers say.

2 Aug 2004

Researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS

Sydney University medical researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS in the latest round of National Health and Medical Research Council program grants.

2 Aug 2004